Reduced Calorie Diet
Reduced Calorie Diet is an intervention with 5 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of a 4-week Alternate Day Intermittent Energy Restriction Intervention vs Reduced
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet
Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects
Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults
Reduced Calorie Diet Intervention in Kidney Transplant Recipients
Clinical Trials (5)
Effect of a 4-week Alternate Day Intermittent Energy Restriction Intervention vs Reduced
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet
Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects
Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults
Reduced Calorie Diet Intervention in Kidney Transplant Recipients
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5